Your browser doesn't support javascript.
loading
Inhibition of factor VIII with a partially inhibitory human recombinant monoclonal antibody prevents thrombotic events in a transgenic model of type II HBS antithrombin deficiency in mice.
Dewerchin, M; Van der Elst, L; Singh, I; Grailly, S; Saint-Remy, J-M; Collen, D; Jacquemin, M.
Affiliation
  • Dewerchin M; Center for Transgene Technology and Gene Therapy, VIB, KULeuven Campus Gasthuisberg, Leuven, Belgium. mieke.dewerchin@med.kuleuven.ac.be
J Thromb Haemost ; 2(1): 77-84, 2004 Jan.
Article in En | MEDLINE | ID: mdl-14717970
Search on Google
Collection: 01-internacional Health context: 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Thrombosis / Factor VIII / Antithrombin III Deficiency / Fibrinolytic Agents / Antibodies, Monoclonal Type of study: Etiology_studies / Prognostic_studies Limits: Animals / Female / Humans / Male Language: En Journal: J Thromb Haemost Year: 2004 Document type: Article
Search on Google
Collection: 01-internacional Health context: 6_ODS3_enfermedades_notrasmisibles Database: MEDLINE Main subject: Thrombosis / Factor VIII / Antithrombin III Deficiency / Fibrinolytic Agents / Antibodies, Monoclonal Type of study: Etiology_studies / Prognostic_studies Limits: Animals / Female / Humans / Male Language: En Journal: J Thromb Haemost Year: 2004 Document type: Article